il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Recurrent WHO Grade III Glioma
City of Hope Medical CenterCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Recurrent WHO Grade III Glioma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUDEOXYGLUCOSE Thomas Hope | Phase 2 | B |
Pamiparib Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1/2 | B |
FET Thomas Hope | Phase 2 | B |
Cediranib City of Hope Medical Center | Phase 1 | CC |
Arm 3: Il13Ra2-Specific Car Tcm Cells City of Hope Medical Center | Phase 1 | CC |
View all 11 →
Same molecule, other indications
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →